Cited by

• Cost-effectiveness of lung cancer screening with volume computed tomography in Portugal.

  Berge HT, Togka K, Pan X, Borges M, Martelo FP, Guedes F, Cabral D, Teixeira E, Fernandes G, Ferreira L, Figueiredo S, Sousa R, Barradas L, Estevinho F, Araújo A, Hespanhol V, Medeiros R. Berge HT, et al. J Comp Eff Res. 2024 Nov;13(11):e240102. doi: 10.57264/cer-2024-0102. Epub 2024 Sep 27. J Comp Eff Res. 2024. PMID: 39329332 Free PMC article.
• The current and future burden of heart failure in Portugal.

  Gouveia M, Ascenção R, Fiorentino F, Costa J, Caldeira D, Broeiro-Gonçalves P, Fonseca C, Borges M. Gouveia M, et al. ESC Heart Fail. 2019 Apr;6(2):254-261. doi: 10.1002/ehf2.12399. Epub 2019 Jan 8. ESC Heart Fail. 2019. PMID: 30620150 Free PMC article.
• Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis.

  Barata F, Fidalgo P, Figueiredo S, Tonin FS, Duarte-Ramos F. Barata F, et al. PLoS One. 2021 Jun 4;16(6):e0252529. doi: 10.1371/journal.pone.0252529. eCollection 2021. PLoS One. 2021. PMID: 34086757 Free PMC article.
• Measuring the indirect cost associated with advanced non-small cell lung cancer: a nationwide cross-sectional study in China.

  Yang Y, Xia Y, Su C, Chen J, Long E, Zhang H, Gan Y, Yan F, Chen Y. Yang Y, et al. J Cancer Res Clin Oncol. 2023 Jul;149(8):4205-4214. doi: 10.1007/s00432-022-04258-w. Epub 2022 Sep 3. J Cancer Res Clin Oncol. 2023. PMID: 36056953 Free PMC article.
• Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.

  Soares M, Antunes L, Redondo P, Borges M, Hermans R, Patel D, Grimson F, Munro R, Chaib C, Lacoin L, Daumont M, Penrod JR, O'Donnell JC, Bento MJ, Rocha Gonçalves F. Soares M, et al. BMC Pulm Med. 2020 Sep 10;20(1):240. doi: 10.1186/s12890-020-01270-z. BMC Pulm Med. 2020. PMID: 32912174 Free PMC article.